Damon Runyon supports young scientists driving cancer research innovation
The Damon Runyon Cancer Research Foundation has named 13 new Damon Runyon Fellows, exceptional postdoctoral scientists conducting basic and…
Nanomedicine offers targeted solutions for breast cancer treatment
Breast cancer (BCA) is one of the most common cancers worldwide, with high mortality and morbidity in women.…
CIPHER-seq technology reveals how immune cells communicate during treatment
A new single-cell technology is giving scientists their clearest view yet of immune cell behavior-capturing not just genetic…
Immunotherapy plus chemotherapy improves outcomes in stage III dMMR colon cancer
A new study from researchers at the Alliance for Clinical Trials in Oncology (Alliance) shows that patients with…
New guidance aims to standardize tumor mutational burden in cancer
Immune checkpoint inhibitors have transformed cancer care, yet only a minority of patients respond to monotherapy, and immune-related…
Blood pressure drug boosts effectiveness of cancer therapy
In a new Dartmouth Cancer Center (DCC) study led by clinical researcher Tyler J. Curiel, MD, MPH, FACP,…
Study revises the understanding of neutrophil dynamics during respiratory viral infection
Neutrophil infiltration is a hallmark of pulmonary inflammation during respiratory viral infections, yet the origin of these cells…
New nanoparticle therapy overcomes T cell exhaustion in solid tumors
Engineers at the University of Pennsylvania have developed a new type of lipid nanoparticle (LNP) that could one…
Blocking fructose metabolism may improve brain tumor immunotherapy response
Northwestern Medicine scientists have discovered that specialized immune cells within the glioblastoma tumor metabolize fructose to suppress immune…
New insights highlight multifaceted roles of CD4+ T cells in tumor immunity
For decades, cancer immunotherapy has focused primarily on CD8+ cytotoxic T lymphocytes as the main executors of tumor…
Defining the limits of immunotherapy in early small-cell lung cancer
Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer…
New strategy boosts immunotherapy against aggressive ovarian cancer
Cells in our immune system are best known for providing security against external invaders such as bacteria and…